Comparison · NCT01778634-e208999b
Azithromycin vs Placebo (5% Dextrose): Number of Participants Who Died
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Azithromycin vs Placebo (5% Dextrose): Number of Participants Who Died. Trial comparisons, record NCT01778634-e208999b. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT01778634-e208999b
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.0833 | 0.0361 | 0.181 | wilson | |
| Risk in group 2 | 0.0984 | 0.0459 | 0.198 | wilson | |
| Risk difference, group 1 minus group 2 | -0.015 | -0.126 | 0.0956 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.847 | 0.273 | 2.63 | log | |
| Odds ratio, group 1 over group 2 | 0.833 | 0.24 | 2.89 | log | |
| Number needed to treat, for one fewer participant with the outcome on Azithromycin than on Placebo (5% Dextrose) | 66.5 | from the risk difference interval | the interval includes no difference |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Azithromycin | Azithromycin intravenous (2 mg/ml) 20 mg/kg every 24h x 3 days~Azithromycin: Azithromycin intravenous 20 mg/kg every 24 h x 3 days | 5 | 60 | OG001 |
| Group 2 | Placebo (5% Dextrose) | Placebo~Placebo: D5W 10 ml/kg every 24 h x 3 days | 6 | 61 | OG000 |
Source ClinicalTrials.gov
Outcome
- Type
- SECONDARY
- Title
- Number of Participants Who Died
- Description
- Number of Participants who died from any cause
- Time frame
- 22-26 months
- Population
Source ClinicalTrials.gov
Trial
- Title
- Trial of Intravenous Azithromycin to Eradicate Ureaplasma Respiratory Tract Infection in Preterm Infants
- NCT number
- NCT01778634
- Phases
- PHASE2
- Conditions
- Ureaplasma Infections
- Interventions
- Azithromycin, Placebo
- Lead sponsor
- University of Maryland, Baltimore
- Results first posted
- 2018-05-17
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT01778634?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT01778634-e208999b